Together we can make a lasting impact
Your support is vital to our mission of funding transformative science and improving survivorship.
Recently diagnosed with lung cancer?
Learn more about your lung cancer diagnosis. What questions should you be asking? What are the most important next steps? Know that you have options and remember that knowledge is power.
Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients
Understanding how the specific genetic background of each cancer affects their behaviors in patients
Cell and molecular biologist
Novel therapies for small cell lung cancer (SCLC)
Research is HOPE. Research will hopefully have me sitting here in #GiveMe20. Give me 20 years post-diagnosis.
Brandi Bryant, living with lung cancer
Your generosity is shaping future leaders in lung cancer research.
Kim Norris, Co-Founder and President
There is such tremendous hope for all patients with lung cancer right now.
Dr. Christine Lovly, LCFA Young Investigator
Word of the Day
HER2, which stands for Human Epidermal Growth Factor Receptor 2, is a protein that can be overexpressed in certain types of lung cancer. HER2 overexpression can contribute to the growth and spread of cancer cells. HER2 mutations tend to be more common in adenocarcinoma non-small cell lung cancer patients with little to no smoking history.